How should I conduct a clamp trial on a percutaneous cholecystostomy tube that is attached to a three‑way port, stopcock, and bulb drain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Perform a Clamp Trial with a Percutaneous Cholecystostomy Tube

To conduct a clamp trial on your percutaneous cholecystostomy tube with a three-way port and stopcock attached to a bulb drain, close the stopcock to occlude drainage for 1-2 weeks while monitoring the patient for recurrent symptoms of cholecystitis before tube removal.

Clamp Trial Procedure

The clamp trial is the preferred method to assess readiness for tube removal, as it is superior to tube cholangiography for predicting safe removal 1. Here's the specific approach:

Step-by-Step Technique

  1. Ensure adequate tube maturation: The tube should remain in place for at least 6 weeks (ideally 44+ days) before attempting a clamp trial 2. Shorter durations are associated with significantly higher recurrence rates (5.6-fold increased risk) 2.

  2. Execute the clamp: Using the stopcock on your three-way port system, turn it to the closed position to prevent bile drainage into the bulb drain. This effectively occludes the tube while keeping it in place.

  3. Duration of clamping: Maintain the tube in the clamped position for 1-2 weeks 2. This extended clamping period significantly reduces recurrence risk (odds ratio 0.108) compared to no clamping 2.

  4. Monitor during the trial: Watch for:

    • Right upper quadrant pain
    • Fever
    • Nausea/vomiting
    • Elevated white blood cell count
    • Signs of sepsis
  5. Interpretation:

    • Successful trial: No symptoms develop during the 1-2 week clamping period → proceed with tube removal
    • Failed trial: Recurrent cholecystitis symptoms → unclamp immediately and consider interval cholecystectomy if the patient becomes a surgical candidate

Critical Timing Considerations

If planning interval cholecystectomy: Remove the tube after a successful clamp trial but schedule surgery for 8-13 weeks after initial tube placement 1. This timing window is crucial:

  • Surgery before 8 weeks: increased complications
  • Surgery after 13 weeks: increased complications
  • Removing the tube before surgery reduces complications but increases risk of emergency cholecystectomy 1

High-Risk Patients Requiring Special Attention

Be particularly cautious with clamp trials in patients with:

  • Common bile duct stones (24-fold increased recurrence risk) 2
  • Calculous cholecystitis (higher recurrence than acalculous) 2
  • Underlying malignancy (3.4-fold increased recurrence risk) 2
  • Congestive heart failure or chronic liver disease (less likely to tolerate interval cholecystectomy) 1

For these patients, consider maintaining the tube longer than 6 weeks and extending the clamp trial duration before removal 2.

Why Clamp Trial Over Cholangiography

The evidence demonstrates that tube cholangiography (tubogram) does not significantly lower recurrence rates 2, while a proper clamp trial does 2. The clamp trial functionally tests whether the cystic duct has adequate patency and whether the gallbladder can drain normally without external decompression 1, 3.

Post-Removal Expectations

Even with successful clamp trials, approximately 20% of patients experience recurrence after definitive tube removal 2, with mean time to recurrence around 660 days. This underscores why interval cholecystectomy remains preferable for surgical candidates, as it reduces the 1-year readmission rate from 49% to much lower levels 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.